--- url: 'https://qubit.capital/blog/europe-series-a-weekly-funding-roundup-mar-13-20-2026' title: 'Europe Series A Weekly Funding Roundup (Mar 13-20, 2026): $101.0M Raised Across 5 Deals' author: name: Sahil Agrawal url: 'https://qubit.capital/blog/author/sahil' date: '2026-03-20T05:07:46+05:30' modified: '2026-03-20T15:12:35+05:30' type: post summary: 'Europe Series A roundup: $101M raised across 5 deals including Validio ($30M), Saltz (€20M), Parallel ($20M), Rivia ($15M), and Orqa (€12.7M) in healthtech, SaaS, deeptech, and food supply.' categories: - Weekly Funding Roundup image: 'https://qubit.capital/wp-content/uploads/2026/03/featured-europe-series-a-64359.webp' published: true --- # Europe Series A Weekly Funding Roundup (Mar 13-20, 2026): $101.0M Raised Across 5 Deals European Series A activity this week delivered $101 million across five deals spanning healthtech, data infrastructure, defense drones, and food supply chain digitization. Sweden and France led the pack with the largest raises, while Croatia and Lithuania demonstrated the growing reach of venture capital across the continent. Two trends stand out. First, healthtech continues to attract serious capital as AI-native startups tackle administrative inefficiencies in hospitals and clinical trials. Second, investors are backing companies that bring software intelligence to traditionally manual industries — from restaurant procurement to military drone operations. The mix of Tier 1 backers like Index Ventures, Lightspeed, and Lakestar signals strong conviction in European founders solving global problems from local footholds. Weekly Funding Roundup MAR 13-20, 2026 $97.7M TOTAL RAISED 5DEALS CLOSED 100%SERIES A $19.54MAVG DEAL SIZE EUROPETOP REGION BY STAGE Series A$97.7M100% BY SECTOR ValidioSaaS / Data Infrastructure$30M SaltzFood Supply Chain / Marketplace$20M ParallelHealthtech / AI$20M RiviaHealthtech / Life Sciences$15M OrqaDeeptech / Defense$12.7M Table of Contents - [1. Validio Raises $30M For Data Quality Automation](#1-validio-raises-$30m-for-data-quality-automation) [Deal Overview](#deal-overview) - [Investor Profile](#investor-profile) - [Company and Leadership](#company-and-leadership) - [Problem and Opportunity](#problem-and-opportunity) - [Product and Technology](#product-and-technology) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision) - [Market Context](#market-context) - [2. Saltz Raises €20M For Food Supply Marketplace](#2-saltz-raises-€20m-for-food-supply-marketplace) [Deal Overview](#deal-overview-1) - [Investor Profile](#investor-profile-1) - [Company and Leadership](#company-and-leadership-1) - [Problem and Opportunity](#problem-and-opportunity-1) - [Product and Technology](#product-and-technology-1) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-1) - [Market Context](#market-context-1) - [3. Parallel Raises $20M For AI Agents in Hospitals](#3-parallel-raises-$20m-for-ai-agents-in-hospitals) [Deal Overview](#deal-overview-2) - [Investor Profile](#investor-profile-2) - [Company and Leadership](#company-and-leadership-2) - [Problem and Opportunity](#problem-and-opportunity-2) - [Product and Technology](#product-and-technology-2) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-2) - [Market Context](#market-context-2) - [4. Rivia Raises $15M For Clinical Trial Data Engine](#4-rivia-raises-$15m-for-clinical-trial-data-engine) [Deal Overview](#deal-overview-3) - [Investor Profile](#investor-profile-3) - [Company and Leadership](#company-and-leadership-3) - [Problem and Opportunity](#problem-and-opportunity-3) - [Product and Technology](#product-and-technology-3) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-3) - [Market Context](#market-context-3) - [5. Orqa Raises €12.7M For Defense Drone Systems](#5-orqa-raises-€12-7m-for-defense-drone-systems) [Deal Overview](#deal-overview-4) - [Investor Profile](#investor-profile-4) - [Company and Leadership](#company-and-leadership-4) - [Problem and Opportunity](#problem-and-opportunity-4) - [Product and Technology](#product-and-technology-4) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-4) - [Market Context](#market-context-4) - [Lessons For Founders](#lessons-for-founders) ## 1. Validio Raises $30M For Data Quality Automation ### Deal Overview - **Stage:** Series A - **Sector:** SaaS / Data Infrastructure - **Geography:** Stockholm, Sweden - **Round Size:** $30M - **Key Investors:** Plural, Lakestar, J12 ### Investor Profile Plural, a European-focused enterprise software fund, led the round alongside Lakestar, known for early bets on Spotify and Revolut. J12 rounds out a syndicate with deep enterprise infrastructure experience. The investor mix reflects confidence that data quality is becoming a board-level priority, not a back-office afterthought. ### Company and Leadership [Validio](https://validio.io) is headquartered in Stockholm and has built a platform that monitors data health across billions of records. The company serves clients in financial services, manufacturing, and telecom — industries where data errors carry outsized consequences. ### Problem and Opportunity Bad data costs enterprises an estimated 15-25% of revenue annually. As companies rely on data for AI models, pricing, compliance, and operations, the cost of undetected quality issues compounds fast. Most organizations still rely on manual checks or basic threshold alerts that miss subtle degradation patterns. ### Product and Technology Validio automates data quality monitoring with anomaly detection that works across billions of records in real time. The platform catches issues that rule-based systems miss — schema drift, distribution shifts, and silent failures in data pipelines. It integrates with existing data stacks without requiring migration. ### Use of Proceeds and Vision The $30M will fund expansion across European and US enterprise markets, deepen integrations with modern data platforms, and grow the engineering team. Validio is positioning itself as the reliability layer every data-driven organization needs as AI adoption accelerates. ### Market Context The data quality market is projected to exceed $3B by 2028, driven by AI and regulatory requirements. Competitors include Monte Carlo, Anomalo, and Bigeye in the US. Validio’s European base and enterprise focus in regulated industries give it a differentiated position. ## 2. Saltz Raises €20M For Food Supply Marketplace ### Deal Overview - **Stage:** Series A - **Sector:** Food Supply Chain / Marketplace - **Geography:** Vilnius, Lithuania - **Round Size:** €20M (~$22M) - **Key Investors:** EBRD, Inovo, Lifeline Ventures, Change Ventures ### Investor Profile The European Bank for Reconstruction and Development (EBRD) anchored this round, bringing institutional credibility and cross-border expansion support. Inovo, one of Central Europe’s most active funds, joined alongside Lifeline Ventures and Change Ventures. EBRD’s involvement signals that Saltz has reached the scale and governance standards required by development finance institutions. ### Company and Leadership [Saltz](https://saltz.com) operates from Vilnius and has built a digital marketplace connecting restaurants directly with food suppliers. The company already operates in approximately 20 countries and counts major hospitality brands including Hilton and Marriott among its clients. ### Problem and Opportunity Restaurant food procurement remains largely manual — phone calls, paper invoices, inconsistent pricing. This creates waste, opacity, and margin pressure across a $300B+ European food service market. The problem is acute for multi-location hospitality groups managing procurement across geographies. ### Product and Technology Saltz digitizes the procurement workflow end to end: supplier discovery, ordering, invoicing, and spend analytics. The platform aggregates suppliers into a single interface, giving restaurants visibility into pricing, quality, and delivery reliability. For suppliers, it opens access to demand they could not reach through traditional sales channels. ### Use of Proceeds and Vision The company plans to hire approximately 100 new employees and expand its European footprint. Funds will also go toward deepening the platform’s analytics capabilities and building out supplier-side tools to increase marketplace density. ### Market Context Food service procurement digitization is still in early innings. Competitors include Choco (Germany), Rekki (UK), and regional players. Saltz’s ~20-country footprint and enterprise client roster suggest strong product-market fit in the hospitality segment specifically. ## 3. Parallel Raises $20M For AI Agents in Hospitals ### Deal Overview - **Stage:** Series A - **Sector:** Healthtech / AI - **Geography:** Paris, France - **Round Size:** $20M - **Key Investors:** Index Ventures, Frst, Y Combinator, Hexa ### Investor Profile Index Ventures, one of Europe’s most prestigious funds with exits including Figma and Datadog, led the round. Y Combinator’s continued backing after the accelerator program signals strong founder-market fit. Notable angels include Arthur Mensch, CEO of Mistral AI, and the Pennylane co-founders — a who’s who of French tech leadership. ### Company and Leadership [Parallel](https://www.beparallel.com) was founded in 2025 by Paul Lafforgue and Chris Rydahl. The company graduated from Y Combinator and raised a $3.5M seed less than a year before closing this Series A. It is already deployed across several dozen public and private hospitals in France. ### Problem and Opportunity Hospital administrative costs represent 25-30% of total healthcare spending. Medical coding — converting clinical information into standardized codes for reimbursement — is particularly time-consuming and error-prone. Hospitals lose revenue from coding mistakes and burn clinical staff hours on paperwork instead of patient care. ### Product and Technology Parallel builds AI agents using large language models and Computer Use Agents to automate hospital administrative tasks, starting with medical coding. The system runs on top of existing hospital software without requiring infrastructure changes or API integrations. This dramatically reduces deployment friction — a critical advantage in risk-averse hospital IT environments. ### Use of Proceeds and Vision Funds will accelerate the rollout of coding agents across more hospitals, support international expansion beyond France, and fund development of new solutions for additional hospital administrative processes. The long-term vision is to become the AI automation layer for hospital operations. ### Market Context Medical coding alone is a $20B+ global market. US competitors include Fathom (acquired by Nabla) and 3M coding solutions. Parallel’s European focus and Computer Use Agent approach are distinctive. The combination of Index Ventures and YC backing gives it credibility in a sector where trust is paramount. ## 4. Rivia Raises $15M For Clinical Trial Data Engine ### Deal Overview - **Stage:** Series A - **Sector:** Healthtech / Life Sciences - **Geography:** Zurich, Switzerland - **Round Size:** $15M - **Key Investors:** Earlybird, Defiant, Speedinvest, Amino Collective, Nina Capital ### Investor Profile Earlybird, a leading European venture firm with deep healthtech experience, led the round. Speedinvest brings its pan-European network, while Amino Collective and Nina Capital add specialized life sciences investing expertise. The five-investor syndicate reflects broad conviction in the clinical trial data infrastructure thesis. ### Company and Leadership [Rivia](https://rivia.ai) is based in Zurich, Switzerland’s thriving life sciences hub. The company has built a clinical trial data engine and AI platform designed for pharmaceutical and biotech companies running complex trials across multiple sites and geographies. ### Problem and Opportunity Clinical trials generate massive volumes of fragmented data across sites, CROs, and regulatory systems. Data cleaning and reconciliation consume up to 40% of trial timelines. With global pharma R&D spending exceeding $250B annually, even small efficiency gains translate into billions in value. ### Product and Technology Rivia’s platform ingests, cleans, and structures clinical trial data using AI, enabling life sciences teams to move faster from raw data to actionable insights. The engine connects disparate data sources into a unified layer that supports regulatory submissions, safety monitoring, and trial optimization. ### Use of Proceeds and Vision The funding will support platform development, expansion of the customer base across European and US pharma companies, and team growth. Rivia aims to become the default data infrastructure for clinical trials, replacing manual data management with AI-powered automation. ### Market Context The clinical trial technology market is expected to reach $12B by 2030. Competitors include Medidata (Dassault), Veeva Vault, and newer entrants like Saama and Flywheel. Rivia’s Swiss base positions it well for European pharma headquarters while the AI-native approach differentiates it from legacy platforms. ## 5. Orqa Raises €12.7M For Defense Drone Systems ### Deal Overview - **Stage:** Series A - **Sector:** Deeptech / Defense - **Geography:** Croatia - **Round Size:** €12.7M (~$14M) - **Key Investors:** Expeditions, Lightspeed Venture Partners, Taiwania Capital, Aymo, Radius Capital ### Investor Profile Lightspeed Venture Partners, a global Tier 1 fund, joined the round alongside Taiwania Capital, a Taiwanese government-backed fund with strategic interest in defense technology. Expeditions led the round, and the geographic diversity of the investor base — spanning Europe, the US, and Asia — reflects the global demand signal for defense drone capabilities. ### Company and Leadership [Orqa](https://orqa.tech) has been building first-person-view (FPV) drone systems since 2018, originally serving the enthusiast and racing drone community. The Croatian company has pivoted to defense applications, leveraging years of hardware iteration and FPV expertise. ### Problem and Opportunity FPV drones have proven decisive in modern conflict, particularly in Ukraine. Military demand for reliable, high-performance FPV systems has surged, but most defense drones are adapted from consumer platforms rather than purpose-built for combat. NATO and allied nations are actively seeking European-made drone suppliers to reduce dependency on non-allied manufacturing. ### Product and Technology Orqa builds integrated FPV drone systems including goggles, controllers, and communication links optimized for defense use. Their years of experience in the enthusiast market gave them deep expertise in low-latency video transmission, signal reliability, and operator ergonomics — all critical for defense applications. The hardware stack is designed and manufactured in Europe. ### Use of Proceeds and Vision Funding will scale defense production capacity, expand NATO market presence, and advance next-generation drone systems. Orqa is positioning itself as a European sovereign drone technology provider at a time when defense procurement is shifting toward allied-nation suppliers. ### Market Context European defense spending is rising sharply, with drone procurement a top priority. The military drone market is projected to exceed $30B by 2030. Competitors include DJI-derived defense modifications, Turkish manufacturers like Baykar, and startups like Auterion and Skydio. Orqa’s European origin and hardware heritage in FPV systems give it a distinctive edge in the NATO procurement landscape. ## Lessons For Founders - **Start where friction is highest, not where markets are biggest.** Parallel chose medical coding — a narrow, painful process — rather than trying to “fix healthcare.” Saltz digitized restaurant procurement, not the entire food supply chain. Specificity wins early deals and builds defensible expertise. - **Existing infrastructure is a feature, not a constraint.** Parallel’s Computer Use Agents work on top of legacy hospital systems. Validio plugs into existing data stacks. Startups that require customers to rip and replace lose to those that layer intelligence onto what already exists. - **Geopolitical shifts create new market openings.** Orqa’s pivot from enthusiast to defense drones capitalized on NATO’s urgent need for European-made systems. Founders should watch policy and procurement shifts as seriously as technology trends. - **Enterprise clients de-risk fundraising narratives.** Saltz naming Hilton and Marriott, Validio serving financial services, and Parallel deploying across dozens of hospitals all gave investors confidence that demand is real, not theoretical. - **Europe’s deep domain expertise is an underrated advantage.** Zurich for life sciences, Stockholm for data infrastructure, Paris for AI — these founders leveraged local ecosystem strengths rather than competing head-on with Silicon Valley generalists.